DecImmune Therapeutics
ID: 5291404A biotechnology company developing peptides and antibodies for inflammation and autoimmunity
2
Funding Rounds
$5.5m
Money raised
Recent Funding Rounds
Overview
A biotechnology company developing peptides and antibodies for inflammation and autoimmunity
- Website:
- Business model: B2B
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Mi***** Ca***** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company DecImmune Therapeutics has raised a total of $5.45m in funding over 2 rounds.
Key Insights:
- DecImmune Therapeutics funding round, February 2013: $2.25m
- DecImmune Therapeutics funding round, September 2010: $3.2m
Industries
DecImmune Therapeutics is active in the following industries: